3,4-dihydroxyphenylacetic acid has been researched along with 1,2,3,4-tetrahydroisoquinoline in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Mizuno, Y; Nagatsu, T; Saitoh, T; Yoshida, M | 1 |
Abe, K; Miyatake, T; Ren, J; Sano, T; Shinohara, T; Taguchi, K; Utsunomiya, I; Wasai, T | 1 |
Antkiewicz-Michaluk, L; Lorenc-Koci, E; Wardas, J; Wierońska, J; Zapała, M | 1 |
3 other study(ies) available for 3,4-dihydroxyphenylacetic acid and 1,2,3,4-tetrahydroisoquinoline
Article | Year |
---|---|
Effect of long-term administration of 1,2,3,4-tetrahydroisoquinoline (TIQ) on striatal dopamine and 3,4-dihydroxyphenylacetic acid (DOPAC) content in mice.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Dopamine; Isoquinolines; Male; Mice; Mice, Inbred C57BL; Phenylacetates; Rats; Rats, Inbred Strains; Tetrahydroisoquinolines; Time Factors | 1988 |
Stereoselective effect of (R)- and (S)-1-methyl-1,2,3,4-tetrahydroisoquinolines on a mouse model of Parkinson's disease.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Carbidopa; Cell Count; Disease Models, Animal; Dopamine; Dopamine Antagonists; Drug Interactions; Homovanillic Acid; Hydroxyindoleacetic Acid; Hypokinesia; Immunohistochemistry; Isoquinolines; Levodopa; Male; Mice; Mice, Inbred C57BL; Neurons; Neuroprotective Agents; Neurotoxins; Parkinsonian Disorders; Serotonin; Stereoisomerism; Substantia Nigra; Tetrahydroisoquinolines; Tyrosine 3-Monooxygenase | 2001 |
Effect of 1,2,3,4,-tetrahydroisoquinoline administration under conditions of CYP2D inhibition on dopamine metabolism, level of tyrosine hydroxylase protein and the binding of [3H]GBR 12,935 to dopamine transporter in the rat nigrostriatal, dopaminergic sy
Topics: 3,4-Dihydroxyphenylacetic Acid; Alcohol Oxidoreductases; Animals; Aryl Hydrocarbon Hydroxylases; Autoradiography; Behavior, Animal; Blotting, Western; Corpus Striatum; Cytochrome P450 Family 2; Dopamine; Dopamine Plasma Membrane Transport Proteins; Drug Administration Schedule; Drug Interactions; Male; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Piperazines; Protein Binding; Psychomotor Performance; Quinine; Rats; Rats, Wistar; Substantia Nigra; Tetrahydroisoquinolines; Time Factors; Tritium; Tyrosine 3-Monooxygenase | 2004 |